Published in Lab Business Week, June 11th, 2006
This trend article about University of Amsterdam is an immediate alert from IncRx to identify developing directions of research.
Study 1: A study from the Netherlands has reported on the tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution.
"Inhibitory antibodies develop in approximately 25% of patients with severe hemophilia following treatment with factor VIII," wrote W.S. Bril and colleagues of the University of Amsterdam.
"In E-16KO or E-17KO mice, in which the factor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-06-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.